Skip to main content
. 2021 Mar 8;13(5):1147. doi: 10.3390/cancers13051147

Figure 2.

Figure 2

Methods to detect TERTp alterations in patients with glioblastoma. The current reference method is the detection of alterations based on sequencing techniques applied to tumor tissue obtained from either lesion resection or from targeted biopsy in cases of non-resectable tumors. The other methods, particularly noninvasive or minimally invasive methods, are still under development and are not yet used in routine clinical practice.